Key result
A review of national guidelines highlights the need for a standardized document to guide risk assessment and management of cardiac implantable electronic devices during radiotherapy.
Why the study?
Despite individual national guidelines and expert consensus documents, increasing radiotherapy use highlights the need for a standardized document to guide CIED risk assessment and management.
This review highlights the need for standardized guidelines to manage the approximately 5% risk of CIED malfunction during radiotherapy.
Answers are grounded in this paper and cite their sources.
RT-related CIED risks warrant cautious periprocedural planning; leaves open unified international guidelines as RT indications expand.
The incidence of cardiac implantable electronic device (CIED) malfunctions caused by radiotherapy (RT) is approximately 5%. Although individual national guidelines and expert consensus documents exist, the increased use of RT to treat various cancers points out the need for a standardized document to guide risk assessment and management of CIEDs during RT. We describe potential adverse RT-related events on CIEDs as well as the proposed mechanism of dysfunction. We review the main current guidelines and recommendations, emphasizing similarities and differences.
No takes yet. Share an insight, caveat, or question.
Mircea et al. (2024) conducted a review in Patients with cardiac implantable electronic devices undergoing radiotherapy. Radiotherapy was evaluated. A review of national guidelines highlights the need for a standardized document to guide risk assessment and management of cardiac implantable electronic devices during radiotherapy.
Synapse has enriched 10 related papers. Consider them for comparative context: